Search

Search results

172 results found

Sarah N. Flier, M.D.

Person: Assistant Professor of Medicine, Harvard Medical School, Director, Gastroenterology Fellowship Training Program, Director, Quality and Safety, Division of Gastroenterology

Dr. Flier is an Assistant Professor of Medicine at Harvard Medical School and staff physician in the Center for Inflammatory Bowel Diseases at Beth Israel Deaconess Medical Center (BIDMC). Within IBD, she has a particular interest in patients transitioning from pediatric to adult GI providers. This...

Glen Doherty, M.D., Ph.D.

Person: Clinical Full Professor, University College Dublin, Consultant Gastroenterologist, St. Vincent's University Hospital and UCD

Glen Doherty graduated from Trinity College Dublin in 1998 with a Gold Medal and 1st Class Hons Degree in Medicine. He completed a PhD degree (2006) in eicosanoid signaling in colorectal cancer at RCSI medical school and the Conway Institute at UCD. Following the award of his Certificate of...

Aoibhlinn O'Toole, M.D.

Person: Consultant Gastroenterologist, Beaumont Hospital, Professor, Royal College of Surgeons in Ireland

Professor Aoibhlinn O'Toole graduated with honours from University College Dublin in 2004. She completed her specialist training in Gastroenterology and General Internal Medicine in St Vincent's University Hospital, Sligo General Hospital and Beaumont Hospital. She was the UCD Newman Scholar in...

Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Treatment Optimization of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease.”. Expert Review of Gastroenterology & Hepatology.

Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease.

Publication: Journal Article

Zhang, Lina, Cortney Cagle, Du Hanh Nguyen, Graziela Scheuer Gomes, Barbora Gromova, Eva Csizmadia, Arian Karimitar, et al. 2025. “Antisense to Human CD39 Dysregulates Immune Metabolism in Inflammatory Bowel Disease.”. Cellular & Molecular Immunology 22 (7): 730-42.

Medical management of acute severe ulcerative colitis in the hospitalized patient.

Publication: Journal Article

Rabinowitz, Loren G, Ajay Gade, and Joseph D Feuerstein. 2025. “Medical Management of Acute Severe Ulcerative Colitis in the Hospitalized Patient.”. Expert Review of Gastroenterology & Hepatology 19 (5): 467-80.

Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.

Publication: Journal Article

Shubow, Sophie, Michele Gunsior, Amy Rosenberg, Yow-Ming Wang, Tara Altepeter, Daphne Guinn, Mohsen Rajabiabhari, et al. 2025. “Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.”. The AAPS Journal 27 (2): 62.

Search

Search results

Sarah N. Flier, M.D.

Glen Doherty, M.D., Ph.D.

Aoibhlinn O'Toole, M.D.

Marie P. Boyle, M.D., Ph.D.

Brenden Smith, M.D.

Grace Geeganage

Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease.

Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease.

Medical management of acute severe ulcerative colitis in the hospitalized patient.

Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.